HEADER LYASE 07-MAR-01 1I72 TITLE HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND TITLE 2 PYRUVOYL GROUP AND COVALENTLY BOUND 5'-DEOXY-5'-[N-METHYL-N-(2- TITLE 3 AMINOOXYETHYL) AMINO]ADENOSINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN; COMPND 3 CHAIN: B; COMPND 4 EC: 4.1.1.50; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN; COMPND 8 CHAIN: A; COMPND 9 EC: 4.1.1.50; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SPERMIDINE BIOSYNTHESIS, LYASE, DECARBOXYLASE, PYRUVATE, S- KEYWDS 2 ADENOSYLMETHIONINE, SANDWICH, ALLOSTERIC ENZYME, PYRUVOYL EXPDTA X-RAY DIFFRACTION AUTHOR W.D.TOLBERT,J.L.EKSTROM,I.I.MATHEWS,J.A.SECRIST III,A.E.PEGG, AUTHOR 2 S.E.EALICK REVDAT 8 16-OCT-24 1I72 1 REMARK REVDAT 7 15-NOV-23 1I72 1 REMARK LINK ATOM REVDAT 6 31-JAN-18 1I72 1 JRNL REVDAT 5 24-JAN-18 1I72 1 JRNL REVDAT 4 29-SEP-10 1I72 1 REMARK REVDAT 3 24-FEB-09 1I72 1 VERSN REVDAT 2 01-APR-03 1I72 1 JRNL REVDAT 1 22-AUG-01 1I72 0 JRNL AUTH W.D.TOLBERT,J.L.EKSTROM,I.I.MATHEWS,J.A.SECRIST III, JRNL AUTH 2 P.KAPOOR,A.E.PEGG,S.E.EALICK JRNL TITL THE STRUCTURAL BASIS FOR SUBSTRATE SPECIFICITY AND JRNL TITL 2 INHIBITION OF HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE. JRNL REF BIOCHEMISTRY V. 40 9484 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11583147 JRNL DOI 10.1021/BI010735W REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.EKSTROM,I.I.MATHEWS,B.A.STANLEY,A.E.PEGG,S.E.EALICK REMARK 1 TITL THE CRYSTAL STRUCTURE OF HUMAN S-ADENOSYLMETHIONINE REMARK 1 TITL 2 DECARBOXYLASE AT 2.25 A RESOLUTION REVEALS A NOVEL FOLD REMARK 1 REF STRUCTURE V. 7 583 1999 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(99)80074-4 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 794418.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 22582 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2238 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3319 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 324 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2533 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 251 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.35000 REMARK 3 B22 (A**2) : 1.21000 REMARK 3 B33 (A**2) : -7.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.63000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.330 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.090 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.870 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.340 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.040 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 32.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEINMAO.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEINMAO.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I72 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAR-01. REMARK 100 THE DEPOSITION ID IS D_1000012985. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 4 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96420 REMARK 200 MONOCHROMATOR : DIAMOND 1 1 1 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23342 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.60 REMARK 200 R MERGE FOR SHELL (I) : 0.22700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TRIS-HCL PH 8.0, REMARK 280 DITHIOTHREITOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.23650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.41650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.23650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.41650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE NATIVE ENZYME IS A DIMER GENERATED BY THE REMARK 300 CRYSTALLOGRAPHIC TWO-FOLD. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -18.15871 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 66.46821 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ALA B 3 REMARK 465 ASP B 24 REMARK 465 ALA B 25 REMARK 465 ASN B 26 REMARK 465 SER A 167 REMARK 465 ARG A 168 REMARK 465 VAL A 169 REMARK 465 ILE A 170 REMARK 465 THR A 294 REMARK 465 VAL A 295 REMARK 465 LEU A 296 REMARK 465 ALA A 297 REMARK 465 SER A 298 REMARK 465 GLN A 329 REMARK 465 GLN A 330 REMARK 465 GLN A 331 REMARK 465 GLN A 332 REMARK 465 GLN A 333 REMARK 465 SER A 334 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 22 -50.28 103.11 REMARK 500 GLN B 48 40.84 76.95 REMARK 500 CYS A 82 -155.92 -131.79 REMARK 500 ASN A 153 17.20 82.65 REMARK 500 SER A 154 -154.34 -155.69 REMARK 500 PRO A 165 -85.44 -56.30 REMARK 500 PHE A 250 40.07 -161.04 REMARK 500 LYS A 301 -65.21 -101.42 REMARK 500 ILE A 302 103.67 60.26 REMARK 500 CYS A 310 108.39 -161.48 REMARK 500 PHE A 315 -166.99 -106.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAO A 368 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PUT A 350 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JEN RELATED DB: PDB REMARK 900 RELATED ID: 1I79 RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, 5'-DEOXY-5'-[(3-HYDRAZINOPROPYL) REMARK 900 METHYLAMINO]ADENOSINE BOUND TO PVL REMARK 900 RELATED ID: 1I7B RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, S-ADENOSYLMETHIONINE METHYL REMARK 900 ESTER BOUND TO PVL REMARK 900 RELATED ID: 1I7C RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, METHYLGLYOXAL BIS- REMARK 900 (GUANYLHYDRAZONE) REMARK 900 RELATED ID: 1I7M RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, 4-AMIDINOINDAN-1-ONE-2'- REMARK 900 AMIDINOHYDRAZONE DBREF 1I72 B 1 67 UNP P17707 DCAM_HUMAN 1 67 DBREF 1I72 A 68 334 UNP P17707 DCAM_HUMAN 68 334 SEQADV 1I72 PYR A 68 UNP P17707 SER 68 SEE REMARK 999 SEQRES 1 B 67 MET GLU ALA ALA HIS PHE PHE GLU GLY THR GLU LYS LEU SEQRES 2 B 67 LEU GLU VAL TRP PHE SER ARG GLN GLN PRO ASP ALA ASN SEQRES 3 B 67 GLN GLY SER GLY ASP LEU ARG THR ILE PRO ARG SER GLU SEQRES 4 B 67 TRP ASP ILE LEU LEU LYS ASP VAL GLN CYS SER ILE ILE SEQRES 5 B 67 SER VAL THR LYS THR ASP LYS GLN GLU ALA TYR VAL LEU SEQRES 6 B 67 SER GLU SEQRES 1 A 267 PYR SER MET PHE VAL SER LYS ARG ARG PHE ILE LEU LYS SEQRES 2 A 267 THR CYS GLY THR THR LEU LEU LEU LYS ALA LEU VAL PRO SEQRES 3 A 267 LEU LEU LYS LEU ALA ARG ASP TYR SER GLY PHE ASP SER SEQRES 4 A 267 ILE GLN SER PHE PHE TYR SER ARG LYS ASN PHE MET LYS SEQRES 5 A 267 PRO SER HIS GLN GLY TYR PRO HIS ARG ASN PHE GLN GLU SEQRES 6 A 267 GLU ILE GLU PHE LEU ASN ALA ILE PHE PRO ASN GLY ALA SEQRES 7 A 267 GLY TYR CYS MET GLY ARG MET ASN SER ASP CYS TRP TYR SEQRES 8 A 267 LEU TYR THR LEU ASP PHE PRO GLU SER ARG VAL ILE SER SEQRES 9 A 267 GLN PRO ASP GLN THR LEU GLU ILE LEU MET SER GLU LEU SEQRES 10 A 267 ASP PRO ALA VAL MET ASP GLN PHE TYR MET LYS ASP GLY SEQRES 11 A 267 VAL THR ALA LYS ASP VAL THR ARG GLU SER GLY ILE ARG SEQRES 12 A 267 ASP LEU ILE PRO GLY SER VAL ILE ASP ALA THR MET PHE SEQRES 13 A 267 ASN PRO CYS GLY TYR SER MET ASN GLY MET LYS SER ASP SEQRES 14 A 267 GLY THR TYR TRP THR ILE HIS ILE THR PRO GLU PRO GLU SEQRES 15 A 267 PHE SER TYR VAL SER PHE GLU THR ASN LEU SER GLN THR SEQRES 16 A 267 SER TYR ASP ASP LEU ILE ARG LYS VAL VAL GLU VAL PHE SEQRES 17 A 267 LYS PRO GLY LYS PHE VAL THR THR LEU PHE VAL ASN GLN SEQRES 18 A 267 SER SER LYS CYS ARG THR VAL LEU ALA SER PRO GLN LYS SEQRES 19 A 267 ILE GLU GLY PHE LYS ARG LEU ASP CYS GLN SER ALA MET SEQRES 20 A 267 PHE ASN ASP TYR ASN PHE VAL PHE THR SER PHE ALA LYS SEQRES 21 A 267 LYS GLN GLN GLN GLN GLN SER HET PYR A 68 4 HET MAO A 368 24 HET PUT A 350 6 HETNAM PYR PYRUVIC ACID HETNAM MAO 5'-DEOXY-5'-[N-METHYL-N-(2-AMINOOXYETHYL) HETNAM 2 MAO AMINO]ADENOSINE HETNAM PUT 1,4-DIAMINOBUTANE HETSYN PUT PUTRESCINE FORMUL 2 PYR C3 H4 O3 FORMUL 3 MAO C13 H21 N7 O4 FORMUL 4 PUT C4 H12 N2 FORMUL 5 HOH *251(H2 O) HELIX 1 1 ASP B 31 ILE B 35 5 5 HELIX 2 2 PRO B 36 ASP B 46 1 11 HELIX 3 3 LEU A 86 LYS A 89 5 4 HELIX 4 4 ALA A 90 GLY A 103 1 14 HELIX 5 5 LYS A 119 GLN A 123 5 5 HELIX 6 6 ASN A 129 ALA A 139 1 11 HELIX 7 7 ASP A 185 ASP A 190 1 6 HELIX 8 8 THR A 199 SER A 207 1 9 HELIX 9 9 ILE A 209 ILE A 213 5 5 HELIX 10 10 TYR A 264 LYS A 276 1 13 SHEET 1 A 8 SER B 50 LYS B 56 0 SHEET 2 A 8 GLN B 60 SER B 66 -1 N ALA B 62 O THR B 55 SHEET 3 A 8 MET A 70 SER A 73 -1 O MET A 70 N TYR B 63 SHEET 4 A 8 ARG A 76 THR A 81 -1 O ARG A 76 N SER A 73 SHEET 5 A 8 LYS B 12 SER B 19 -1 N LYS B 12 O THR A 81 SHEET 6 A 8 SER A 106 LYS A 115 -1 N SER A 106 O SER B 19 SHEET 7 A 8 CYS A 156 LEU A 162 -1 N TYR A 158 O ARG A 114 SHEET 8 A 8 GLY A 144 GLY A 150 -1 O ALA A 145 N THR A 161 SHEET 1 B 8 VAL A 217 MET A 222 0 SHEET 2 B 8 TYR A 228 MET A 233 -1 O SER A 229 N THR A 221 SHEET 3 B 8 TYR A 239 THR A 245 -1 O TRP A 240 N GLY A 232 SHEET 4 B 8 TYR A 252 THR A 257 -1 O TYR A 252 N THR A 245 SHEET 5 B 8 GLN A 175 LEU A 184 -1 N LEU A 177 O THR A 257 SHEET 6 B 8 PRO A 277 ASN A 287 -1 N GLY A 278 O SER A 182 SHEET 7 B 8 TYR A 318 LYS A 327 -1 N ASN A 319 O VAL A 286 SHEET 8 B 8 PHE A 305 MET A 314 -1 N LYS A 306 O ALA A 326 LINK C PYR A 68 N SER A 69 1555 1555 1.34 LINK CA PYR A 68 N MAO A 368 1555 1555 1.35 CISPEP 1 TYR A 125 PRO A 126 0 0.09 CISPEP 2 ASN A 224 PRO A 225 0 0.02 SITE 1 AC1 17 PYR A 68 SER A 69 PHE A 223 CYS A 226 SITE 2 AC1 17 GLY A 227 TYR A 228 SER A 229 HIS A 243 SITE 3 AC1 17 ILE A 244 THR A 245 PRO A 246 GLU A 247 SITE 4 AC1 17 HOH A 556 PHE B 7 LEU B 65 SER B 66 SITE 5 AC1 17 GLU B 67 SITE 1 AC2 9 PHE A 111 ASP A 174 THR A 176 TYR A 318 SITE 2 AC2 9 HOH A 406 HOH A 417 HOH A 499 LEU B 13 SITE 3 AC2 9 GLU B 15 CRYST1 100.473 50.833 68.904 90.00 105.28 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009953 0.000000 0.002720 0.00000 SCALE2 0.000000 0.019672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015045 0.00000 CONECT 500 501 502 504 CONECT 501 500 CONECT 502 500 503 2536 CONECT 503 502 CONECT 504 500 CONECT 2536 502 2537 CONECT 2537 2536 2538 CONECT 2538 2537 2539 CONECT 2539 2538 2540 CONECT 2540 2539 2541 2542 CONECT 2541 2540 CONECT 2542 2540 2543 CONECT 2543 2542 2544 2558 CONECT 2544 2543 2545 CONECT 2545 2544 2546 2556 CONECT 2546 2545 2547 2555 CONECT 2547 2546 2548 2553 CONECT 2548 2547 2549 CONECT 2549 2548 2550 CONECT 2550 2549 2551 CONECT 2551 2550 2552 2553 CONECT 2552 2551 CONECT 2553 2547 2551 2554 CONECT 2554 2553 2555 CONECT 2555 2546 2554 CONECT 2556 2545 2557 2558 CONECT 2557 2556 CONECT 2558 2543 2556 2559 CONECT 2559 2558 CONECT 2560 2561 CONECT 2561 2560 2562 CONECT 2562 2561 2563 CONECT 2563 2562 2564 CONECT 2564 2563 2565 CONECT 2565 2564 MASTER 305 0 3 10 16 0 8 6 2814 2 35 27 END